CMBA
RGEN icon

C.M. Bidwell & Associates’s Repligen RGEN Stock Holding History

C.M. Bidwell & Associates’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-115
Closed -$30K – 594
2021
Q4 		$30K Hold
115
– – 0.02% 337
2021
Q3 		$33K Hold
115
– – 0.02% 338
2021
Q2 		$23K Hold
115
– – 0.02% 343
2021
Q1 		$22K Hold
115
– – 0.02% 343
2020
Q4 		$22K Sell
115
-1,179
-91% -$215K 0.02% 333
2020
Q3 		$191K Buy
1,294
+1,057
+446% +$151K 0.18% 119
2020
Q2 		$29K Buy
+237
New +$27.9K 0.03% 279
2019
Q3 		– Sell
-980
Closed -$84K – 472
2019
Q2 		$84K Buy
+980
New +$66.8K 0.08% 191

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

C.M. Bidwell & Associates's RGEN Position: Q1 2022 in Review

C.M. Bidwell & Associates sold out of Repligen (RGEN) in Q1 2022, closing a stake of 115 shares — an estimated $30K sold.

C.M. Bidwell & Associates first reported a position in RGEN in Q2 2019 and held it in 8 quarters. The position peaked at $191K in Q3 2020. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.

  • C.M. Bidwell & Associates reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 115 Repligen shares in Q1 2022, an estimated $30K.
  • C.M. Bidwell & Associates first reported a position in Repligen in Q2 2019 and held it in 8 quarters.
  • C.M. Bidwell & Associates's Repligen position peaked at $191K in Q3 2020.
  • 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.